Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Alpha Tau Medical Stock Quote

Alpha Tau Medical (NASDAQ: DRTS)

$2.40
(-0.2%)
-$0.00
Price as of April 29, 2024, 1:24 p.m. ET

Alpha Tau Medical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
DRTS -17.64% -76%
S&P +23.33% +73.48% +11.63% +33%

Alpha Tau Medical Company Info

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. It focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.